Ironwood Pharmaceuticals Correlations

IRWD Stock  USD 3.34  0.18  5.11%   
The current 90-days correlation between Ironwood Pharmaceuticals and Amphastar P is 0.48 (i.e., Very weak diversification). The correlation of Ironwood Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Ironwood Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Ironwood Pharmaceuticals and DJI is 0.5 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ironwood Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.

Moving together with Ironwood Stock

  0.68VRAX Virax Biolabs GroupPairCorr
  0.61REVB Revelation BiosciencesPairCorr
  0.61STOK Stoke TherapeuticsPairCorr
  0.66BDRX Biodexa Pharmaceticals Upward RallyPairCorr
  0.74CYTK CytokineticsPairCorr

Moving against Ironwood Stock

  0.46VRDN Viridian TherapeuticsPairCorr
  0.4EWTX Edgewise TherapeuticsPairCorr
  0.34BMEA Biomea FusionPairCorr
  0.33PRAX Praxis Precision MedPairCorr
  0.66T ATT Inc Aggressive PushPairCorr
  0.59PTAIF PT Astra InternationalPairCorr
  0.54HD Home DepotPairCorr
  0.53WMT Walmart Aggressive PushPairCorr
  0.49IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.44TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.42DIS Walt Disney Aggressive PushPairCorr
  0.41CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AVDLNBIX
EGRXAVDL
AVDLANIP
PCRXITCI
ANIPNBIX
EGRXCOLL
  
High negative correlations   
ITCICOLL
EGRXPCRX
EGRXITCI
PCRXCOLL
PCRXNBIX
DCPHITCI

Risk-Adjusted Indicators

There is a big difference between Ironwood Stock performing well and Ironwood Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ironwood Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NBIX  1.50 (0.37) 0.00 (0.19) 0.00 
 3.10 
 19.99 
AMPH  1.58 (0.15) 0.00 (0.04) 0.00 
 3.37 
 17.30 
COLL  1.88 (0.36) 0.00 (0.24) 0.00 
 3.59 
 12.29 
ANIP  1.83 (0.25) 0.00 (0.11) 0.00 
 3.70 
 10.82 
ALKS  1.70 (0.14)(0.04) 0.00  2.11 
 4.14 
 9.74 
ITCI  1.36  0.10  0.05  0.20  1.45 
 3.04 
 16.17 
DCPH  1.66 (0.22) 0.00 (0.90) 0.00 
 3.27 
 9.66 
PCRX  1.88  0.23  0.11  0.29  1.93 
 3.96 
 10.38 
AVDL  2.30 (0.61) 0.00 (0.60) 0.00 
 2.90 
 39.15 
EGRX  3.94 (1.28) 0.00 (1.22) 0.00 
 9.24 
 53.71 

Ironwood Pharmaceuticals Corporate Management

Thomas McCourtChief Commercial Officer and Sr. VP of Marketing and SalesProfile
Jana NoeldekeBasel LeaderProfile
Ronald SilverCorporate OfficerProfile
Marcel MoulaisonVice OperationsProfile
Beth CalitriHead RelationsProfile
Sravan EmanyPrincipal VPProfile